There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
To determine clinical outcomes in patients who received ceftaroline (Teflaro) 600 mg
intravenously every 8 or 12 hours after failing or developing intolerance to first-line
agents including vancomycin, daptomycin, or linezolid.